MedTrace Logo

Treatment of Initial Clostridium Difficile Infection

NCT03107169 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2017-04-18

No results posted yet for this study

Summary

Investigators designed an open, two-arm study to compare oral vancomycin with a fecal microbiota transplant (FMT) from a fecal donor-unrelated donor mix (FURM) as treatments for the first Clostridium difficile infection (CDI) episode among hospitalized patients.

Conditions

  • Clostridium Difficile Infection

Interventions

OTHER

FMT

Patients in the FMT group received FMT-FURM

DRUG

Vancomycin

Patients in the vancomycin group received oral vancomycin (250 mg every 6 h for 10-14 days)

Sponsors & Collaborators

  • Universidad Autonoma de Nuevo Leon

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-01
Primary Completion
2015-09-30
Completion
2015-09-30

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03107169 on ClinicalTrials.gov